The effectiveness of Detrositol and Omnic in reducing the discomfort caused by embedding the ureter stent
Phase 3
Recruiting
- Conditions
- reteral stone.Calculus of lower urinary tract
- Registration Number
- IRCT20190624043991N13
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients candidates for Transurethral lithotripsy surgery for unilateral ureteral stones for the first time
Age range 18-50 years
Consent to participate in the study
Exclusion Criteria
No symptoms of BPH
No history of any disease and treatment for prostatitis, cystitis and urinary symptoms
No chronic side pain
No history of ureteral stent placement in any of the ureters
Not pregnant
No history of urinary tract infection
No history of chronic gastrointestinal pain
No psychological illness, Malignancy
No history of allergies or side effects of Tamsulosin and Tolterodine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduce complications from ureteral stents. Timepoint: The first day of surgery and one week after taking the medication, and before removing the stent. Method of measurement: Clinical Symptoms Questionnaire, Urine test and abdominal ultrasound.
- Secondary Outcome Measures
Name Time Method